Clinical Trials
4 trialsNCT05991388 2026-02-20
Glo-BNHL
University of Birmingham
Phase 2/3 Recruiting
NCT02910063 2021-01-13
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Amgen
Phase 2/3 Completed
NCT03391726 2018-01-05
CCFRRBL
Fujian Medical University
Phase 2/3 Unknown
NCT00147121 2016-09-22
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
Japan Clinical Oncology Group
Phase 2/3 Completed